DR Aimee K. Armstrong
MD, FAAP, FACC, FSCAI, FPICS
Director, Cardiac Catheterization & Interventional TherapiesThe Heart Center, Nationwide Children's Hospital
Professor of Pediatrics The Ohio State University College of Medicine
Columbus, Ohio
Aimee K. Armstrong, MD, FAAP, FACC, FSCAI, FPICS is the Director of Cardiac Catheterization & Interventional Therapies at Nationwide Children's Hospital. She is also a Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Armstrong completed her pediatric residency at James Whitcomb Riley Hospital for Children (Indianapolis) and her pediatric cardiology and interventional fellowships at the University of Michigan C.S. Mott Children's Hospital. She is triple-boarded in Pediatrics, Pediatric Cardiology, and Adult Congenital Heart Disease.
Much for her career has been focused on teaching and mentoring the next generation of interventionalists. She is the founder and director of the Interventional Cardiology Fellowship Program at Nationwide Children’s Hospital and was the Founding Chair of the PICS Society Early Career Development Committee. Her love of mentorship and faculty development is evidenced by her being awarded the 2021 Pediatric Interventional Cardiology Early Career Society (PICES) Mentorship Award. Dr. Armstrong’s educational pursuits also include extensive symposium leadership, including co-founding and co-directing 3DI3 and serving as the CHD topic coordinator for ACC.20/World Congress of Cardiology Annual Scientific Sessions, the CHD Program Chair for SCAI 2023, and a co-director of PICS Symposium (2020-present) and PICS Istanbul.
She also has a passion for device development and is the animal lab PI for an NIH/NHLBI grant to develop a transcatheter pulmonary flow restrictor with Starlight Cardiovascular. In addition, she is the national PI for the upcoming Lifeline™ Ductus Arteriosus Stent IDE Study. Dr. Armstrong is collaborating with industry and MR physicists to use a low-field (0.55T) MR scanner for real-time guidance of cardiovascular interventions and working with tissue engineers to develop a bioresorbable transcatheter tissue engineered heart valve for fetuses and infants. Her research efforts also extend to registry work, including directing the SERVE registry for self-expanding pulmonary valves.